The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Pato, M. T.
* Articles by Murphy, D. L.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Pato, M. T.
* Articles by Murphy, D. L.

Am J Psychiatry 1991; 148:127-129
Copyright © 1991 by American Psychiatric Association


BRIEF REPORTS

Controlled comparison of buspirone and clomipramine in obsessive- compulsive disorder

MT Pato, TA Pigott, JL Hill, GN Grover, S Bernstein and DL Murphy
Laboratory of Clinical Science, NIMH, NIH, Bethesda, Md.

Eighteen outpatients with obsessive-compulsive disorder were treated with either buspirone, a partial serotonin agonist, or clomipramine, a serotonin uptake inhibitor, in a double-blind, random-assignment study. Both drugs led to statistically significant and similar improvements in scores on the Yale-Brown Obsessive-Compulsive Rating Scale and other obsessive-compulsive and depression scales. This preliminary result warrants further exploration with a larger sample and other serotonergic agents.


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
D. Nutt and A. Malizia
Anxiety and OCD - the chicken or the egg?
J Psychopharmacol, November 1, 2006; 20(6): 729 - 731.
[PDF]


Home page
NEJMHome page
M. A. Jenike
Obsessive-Compulsive Disorder
N. Engl. J. Med., January 15, 2004; 350(3): 259 - 265.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. Millan, S. Hjorth, R. Samanin, R. Schreiber, R. Jaffard, B. De Ladonchamps, S. Veiga, B. Goument, J.-L. Peglion, M. Spedding, et al.
S 15535, A Novel Benzodioxopiperazine Ligand of Serotonin (5-HT)1A Receptors: II. Modulation of Hippocampal Serotonin Release in Relation to Potential Anxiolytic Properties
J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 148 - 161.
[Abstract] [Full Text]


Home page
J PsychopharmacolHome page
J.V. Lucey
BAP/SKB Young Psychopharmacologist Award Towards a neuroendocrinology of obsessive-compulsive disorder
J Psychopharmacol, January 1, 1994; 8(4): 250 - 257.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
J.F.W. Deakin
A review of clinical efficacy of 5-HT 1A agonists in anxiety and depression
J Psychopharmacol, January 1, 1993; 7(3): 283 - 289.
[PDF]


Home page
Sex AbuseHome page
H.J. Pearson, W.L. Marshall, H.E. Barbaree, and S. Southmayd
Treatment of a Compulsive Paraphiliac With Buspirone
Sexual Abuse: A Journal of Research and Treatment, January 1, 1992; 5(4): 239 - 246.
[Abstract] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
M. A. Jenike
Geriatric Obsessive-Compulsive Disorder
J Geriatr Psychiatry Neurol, January 1, 1991; 4(1): 34 - 39.
[PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1991 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org